0001415889-24-012847.txt : 20240510
0001415889-24-012847.hdr.sgml : 20240510
20240510160545
ACCESSION NUMBER: 0001415889-24-012847
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240508
FILED AS OF DATE: 20240510
DATE AS OF CHANGE: 20240510
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LYONS GARY A
CENTRAL INDEX KEY: 0001123343
ORGANIZATION NAME:
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36257
FILM NUMBER: 24934791
MAIL ADDRESS:
STREET 1: 12790 EL CAMINO REAL
STREET 2: C/O NEUROCRINE BIOSCIENCES
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Travere Therapeutics, Inc.
CENTRAL INDEX KEY: 0001438533
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 262383102
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3611 VALLEY CENTRE DR
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 888-969-7879
MAIL ADDRESS:
STREET 1: 3611 VALLEY CENTRE DR
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: Retrophin, Inc.
DATE OF NAME CHANGE: 20130220
FORMER COMPANY:
FORMER CONFORMED NAME: Desert Gateway, Inc.
DATE OF NAME CHANGE: 20080625
4
1
form4-05102024_040530.xml
X0508
4
2024-05-08
0001438533
Travere Therapeutics, Inc.
TVTX
0001123343
LYONS GARY A
C/O TRAVERE THERAPEUTICS, INC.
3611 VALLEY CENTRE DR., SUITE 300
SAN DIEGO
CA
92130
true
false
false
false
0
Common Stock
2024-05-08
4
A
0
6500
0
A
51000
D
Stock option (right to buy)
6.82
2024-05-08
4
A
0
19500
0
A
2025-05-08
2034-05-07
Common Stock
19500
19500
D
Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program.
The equity award vests over a one year period.
/s/ Elizabeth E. Reed, Attorney-in-Fact
2024-05-10